Researchers have criticised the UK drug industry trade association’s decision to restore Novo Nordisk’s membership despite the company being subject to ongoing regulatory breaches during its two year ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

A WOMAN has left ht internet stunned after losing 8 stone in just 9 months with Mounjaro. Jess, from the UK, says she is so ...

Novo Nordisk became only the eighth company to be suspended from the ABPI in its 40-year history for several transgressions, the most serious of which was a breach of Clause 2 of the code, deemed to ...

Novo Nordisk has been accepted back into the fold. Two years after suspending Novo, the Association of the British ...

Deborah Grayson, a top pharmacist and nutritional therapist, has warned that weight loss medication can cause an inflamed ...

People using weight-loss injections are being warned of potential side effects that could impact their ability to drive ...

As the global demand for obesity treatments skyrockets, Vikrant Shrotriya discusses the complex nature of obesity, the science behind weight management, and the role of medications like Ozempic in ...

People on Ozempic and other GLP-1 agonist drugs commonly report they no longer have constant, incessant thoughts about food. This is how the drugs work.

These GLP-1 agonists include semaglutide, liraglutide, and dulaglutide, now marketed as Ozempic, Wegovy, Saxenda, Victoza, and Trulicity. It remained unclear, however, whether physicians should ...

Weight loss jabs - such as Mounjaro, Wegovy and Saxenda have been rolled out across the UK. But just a fraction of those who are taking the drug have been prescribed it by the NHS, with others ...

Slimmers taking Mounjaro for weight loss account for 10 of the total up to the end of January, with others linked to injections including Ozempic, Wegovy and Saxenda. Ade Robinson, 60, of Burton ...